OTCMKTS:ELOX - Eloxx Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$11.24 -0.29 (-2.52 %)
(As of 12/16/2018 04:00 PM ET)
Previous Close$11.24
Today's Range$11.0650 - $12.0150
52-Week Range$5.80 - $24.60
Volume35,634 shs
Average Volume79,976 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.

Receive ELOX News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ELOX
Previous Symbol
CUSIPN/A
Phone858-909-0749

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees15
Outstanding Shares35,130,000
Market Cap$0.00
OptionableNot Optionable

Eloxx Pharmaceuticals (OTCMKTS:ELOX) Frequently Asked Questions

What is Eloxx Pharmaceuticals' stock symbol?

Eloxx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ELOX."

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals (OTCMKTS:ELOX) announced its earnings results on Thursday, November, 8th. The company reported ($0.32) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.35) by $0.03. View Eloxx Pharmaceuticals' Earnings History.

What price target have analysts set for ELOX?

4 brokerages have issued twelve-month price objectives for Eloxx Pharmaceuticals' shares. Their predictions range from $20.00 to $31.00. On average, they anticipate Eloxx Pharmaceuticals' stock price to reach $25.25 in the next year. This suggests a possible upside of 124.6% from the stock's current price. View Analyst Price Targets for Eloxx Pharmaceuticals.

What is the consensus analysts' recommendation for Eloxx Pharmaceuticals?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eloxx Pharmaceuticals.

Has Eloxx Pharmaceuticals been receiving favorable news coverage?

News stories about ELOX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eloxx Pharmaceuticals earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are some of Eloxx Pharmaceuticals' key competitors?

Some companies that are related to Eloxx Pharmaceuticals include Intrexon (XON), National Research (NRCIB), National Research (NRCIA), Redpoint Bio (RPBC) and VIRALYTICS Ltd/S (VRACY).

Who are Eloxx Pharmaceuticals' key executives?

Eloxx Pharmaceuticals' management team includes the folowing people:
  • Mr. Robert E. Ward, Chairman & CEO (Age 60)
  • Dr. Silvia Noiman, Founder & Director (Age 62)
  • Mr. Gregory L. Weaver CPA, M.B.A., Chief Financial Officer (Age 62)
  • Dr. Pedro Huertas, Chief Medical Officer (Age 63)
  • Dr. Colin Scott M.B., Ch.B., Medical Director (Age 66)

Who are Eloxx Pharmaceuticals' major shareholders?

Eloxx Pharmaceuticals' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Menora Mivtachim Holdings LTD. (5.40%), BlackRock Inc. (3.13%), Vanguard Group Inc (2.44%), Vanguard Group Inc. (2.44%), Altshuler Shaham Ltd (2.42%) and TIAA CREF Investment Management LLC (0.12%). Company insiders that own Eloxx Pharmaceuticals stock include Gilad Shabtai, Gregory L Weaver, Pontifax Management 4 GP (20, Robert Ward, Tomer Kariv and Zafrira Avnur. View Institutional Ownership Trends for Eloxx Pharmaceuticals.

Which institutional investors are selling Eloxx Pharmaceuticals stock?

ELOX stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC. View Insider Buying and Selling for Eloxx Pharmaceuticals.

Which institutional investors are buying Eloxx Pharmaceuticals stock?

ELOX stock was bought by a variety of institutional investors in the last quarter, including Altshuler Shaham Ltd, Vanguard Group Inc, Vanguard Group Inc., Menora Mivtachim Holdings LTD., BlackRock Inc. and MetLife Investment Advisors LLC. Company insiders that have bought Eloxx Pharmaceuticals stock in the last two years include Gilad Shabtai, Gregory L Weaver, Pontifax Management 4 GP (20, Robert Ward, Tomer Kariv and Zafrira Avnur. View Insider Buying and Selling for Eloxx Pharmaceuticals.

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Eloxx Pharmaceuticals' stock price today?

One share of ELOX stock can currently be purchased for approximately $11.24.

What is Eloxx Pharmaceuticals' official website?

The official website for Eloxx Pharmaceuticals is http://www.eloxxpharma.com.

How can I contact Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals' mailing address is 950 WINTER STREET, WALTHAM MA, 02451. The company can be reached via phone at 858-909-0749 or via email at [email protected]


MarketBeat Community Rating for Eloxx Pharmaceuticals (OTCMKTS ELOX)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  149 (Vote Underperform)
Total Votes:  257
MarketBeat's community ratings are surveys of what our community members think about Eloxx Pharmaceuticals and other stocks. Vote "Outperform" if you believe ELOX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELOX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Featured Article: Cash Flow

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel